Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Xiang, Rong  [Clear All Filters]
2022
Wei F, Gong L, Lu S, Zhou Y, Liu L, Duan Z, Xiang R, Gonzalez FJ, Li G. Circadian transcriptional pathway atlas highlights a proteasome switch in intermittent fasting. Cell Rep. 2022;41(4):111547.
2019
Wang X, Yu C, Wang C, Ma Y, Wang T, Li Y, Huang Z, Zhou M, Sun P, Zheng J, et al. Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer stemness activity against non-small-cell lung cancer. Eur J Med Chem. 2019;181:111535.
Gong P, Wang H, Zhang J, Fu Y, Zhu Z, Wang J, Yin Y, Wang H, Zhou Z, Yang J, et al. Telomere Maintenance-Associated PML Is a Potential Specific Therapeutic Target of Human Colorectal Cancer. Transl Oncol. 2019;12(9):1164-1176.
2016
Yang L, Zhang Y, Cheng L, Yue D, Ma J, Zhao D, Hou X, Xiang R, Cheng P. Mesenchymal stem cells engineered to secrete pigment epithelium derived factor inhibit tumor metastasis and the formation of malignant ascites in a murine colorectal peritoneal carcinomatosis model. Hum Gene Ther. 2016.
Xie N, Yuan K, Zhou L, Wang K, Chen H-N, Lei Y, Lan J, Pu Q, Gao W, Zhang L, et al. PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation. Autophagy. 2016.
2015
Zhang W, Yang H, Zhang Y, Lu Y, Zhou T, Li M, Wen Y, Lin X, Xiang R, Chen X. A biotherapy based on PSCs-in-3D spheroid-ameliorated biologics depletes in vivo cancer-sustaining stem cells. Oncotarget. 2015.
2013
Chen S, Li X, Lu D, Xu Y, Mou W, Wang L, Chen Y, Liu Y, Li X, Li L-Y, et al. SOX2 regulates apoptosis through MAP4K4-Survivin signaling pathway in human lung cancer cells. Carcinogenesis. 2013.